The epigenetic modifier EZH2 controls melanoma growth and metastasis through silencing of distinct tumour suppressorsDaniel Zingg, Lukas Sommer|Nature Communications|2015Cited by 332
Truncated FGFR2 is a clinically actionable oncogene in multiple cancersDaniel Zingg, Jos Jonkers|Nature|2022Cited by 130